Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1984;69:15-21

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, A. K.
Right arrow Articles by Walsh, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, A. K.
Right arrow Articles by Walsh, P. N.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Circulation, Vol 69, 15-21, Copyright © 1984 by American Heart Association


ARTICLES

Coagulant activities of platelets in coronary artery disease

AK Rao, PD Mintz, SJ Lavine, AA Bove, MT McDonough, JF Spann and PN Walsh

Platelets have been implicated in the pathogenesis of coronary artery disease, and a number of studies have examined platelet function and coagulation parameters in such patients. We have examined platelet coagulant activities, volumes, and aggregate ratios in 23 patients with chest pain, seven of whom had normal coronary angiograms (group I) and 16 of whom had angiographically proven coronary artery disease (group II). There were no significant differences in the mean values for platelet volume or platelet aggregate ratios between the two groups. The platelet coagulant activities concerned with initiation and the early stages of intrinsic coagulation were significantly increased in patients in group II as compared with those in group I. No significant differences were noted between the two groups with respect to prothrombin time, partial thromboplastin time, and plasma levels of fibrinogen and coagulation factors V and VIII. However, the mean activity in plasma of antithrombin III (but not the level of antithrombin III antigen) was significantly lower in patients of group II compared with group I. Overall, our observations provide evidence for an enhanced contribution of platelets to the intrinsic coagulation system in patients with coronary artery disease. The platelet coagulant hyperactivity noted in these patients may reflect a role of platelets in the pathogenesis of coronary artery disease or may be secondary to the underlying arterial disease.


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
M. Hayakawa and F. Kuzuya
Effects of Ticlopidine on Erythrocyte Aggregation in Thrombotic Disorders
Angiology, September 1, 1991; 42(9): 747 - 753.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
V. Mukerji, B. D. Beitman, M. A. Alpert, J. W. Lamberti, L. DeRosear, and I. M. Basha
Panic Disorder: A Frequent Occurrence in Patients with Chest Pain and Normal Coronary Arteries
Angiology, March 1, 1987; 38(3): 236 - 240.
[Abstract] [PDF]